To Whom It May Concern:
"The Endocrine Society strongly opposes the proposed rule, which would deny access to gender affirming care to the Florida Medicaid population. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions. Many of our 18,000 members are recognized for their expertise in transgender medicine and research.
Our comments below are focused on responding to inaccurate and misleading statements about the Endocrine Society’s clinical practice guidelines made in the report Generally Accepted Professional Medical Standards Determination on the Treatment of Gender Dysphoria (GAPMS) developed by Florida Medicaid in June 2022, which is used to justify the proposed rule."
Read the Full Letter